CXCL10, in addition to inducing effector Th1 cells, also recruits CXCR3+CD8+ T cells to tumor sites and induces granzyme-b production through these cells, thereby enhancing the anti-tumor effect (43). Here, CXCL10 is linked to neoplasm.